May 27, 2008; 70 (22 Part 2) Contemporary Issues in Neurologic Practice
Clinical consequences of generic substitution of lamotrigine for patients with epilepsy
J. LeLorier, M. S. Duh, P. E. Paradis, P. Lefebvre, J. Weiner, R. Manjunath, O. Sheehy
First published May 27, 2008, DOI: https://doi.org/10.1212/01.wnl.0000313154.55518.25
J. LeLorier
M. S. Duh
P. E. Paradis
P. Lefebvre
J. Weiner
R. Manjunath
Clinical consequences of generic substitution of lamotrigine for patients with epilepsy
J. LeLorier, M. S. Duh, P. E. Paradis, P. Lefebvre, J. Weiner, R. Manjunath, O. Sheehy
Neurology May 2008, 70 (22 Part 2) 2179-2186; DOI: 10.1212/01.wnl.0000313154.55518.25
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 70 no. 22 Part 2 2179-2186
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published May 27, 2008.
Copyright & Usage:
© 2008
Author Disclosures
- J. LeLorier, MD, PhD,
- M. S. Duh, MPH, ScD,
- P. E. Paradis, MA, DESS,
- P. Lefebvre, MA,
- J. Weiner, MPA,
- R. Manjunath, MSPH and
- O. Sheehy, MSc
- J. LeLorier, MD, PhD,
- M. S. Duh, MPH, ScD,
- P. E. Paradis, MA, DESS,
- P. Lefebvre, MA,
- J. Weiner, MPA,
- R. Manjunath, MSPH and
- O. Sheehy, MSc
- From the Centre de Recherche (J.L., O.S.), Centre Hospitalier de l'Université de Montréal; Analysis Group, Inc. (M.S.D., J.W.), Boston, MA; Groupe d'Analyse Ltée (P.E.P., P.L.), Montréal, Québec, Canada; and GlaxoSmithKline (R.M.), Research Triangle Park, NC.
- Address correspondence and reprint requests to Dr. Mei Sheng Duh, Vice President, Analysis Group, Inc., 111 Huntington Avenue, Tenth Floor, Boston, MA 02199 mduh{at}analysisgroup.com
Article usage
Letters: Rapid online correspondence
- Clinical consequences of generic substitution of lamotrigine for patients with epilepsy
- Laura S. Boylan, New York University School of Medicine, 462 First Ave H7W11, New York, NY 10016laura.boylan@nyumc.org
Submitted October 02, 2008 - Reply from the authors
- J. LeLorier, MD, PhD, Centre de Recherche, Montréal, Québec, Canadajacques.le.lorier@umontreal.ca
- M. S. Duh, MPH, ScD, P. E. Paradis, MA, DESS, P. Lefebvre, MA, . Weiner, MPA, R. Manjunath, MSPH and O. Sheehy, MSc
Submitted October 02, 2008
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Generic antiepileptic drugs and associated medical resource utilization in the United StatesD.M. Labiner, P.E. Paradis, R. Manjunath et al.Neurology, April 14, 2010 -
Articles
The risks and costs of multiple-generic substitution of topiramateM. S. Duh, P. E. Paradis, D. Latrémouille-Viau et al.Neurology, June 15, 2009 -
Articles
Generic substitution in the treatment of epilepsyCase evidence of breakthrough seizuresM. J. Berg, R. A. Gross, K. J. Tomaszewski et al.Neurology, August 11, 2008 -
Drugs and Devices
Generic substitution of antiepileptic drugsWhat's a clinician to do?Michael Privitera et al.Neurology: Clinical Practice, April 15, 2013